International Research Journal of Commerce , Arts and Science

 ( Online- ISSN 2319 - 9202 )     New DOI : 10.32804/CASIRJ

Impact Factor* - 6.2311


**Need Help in Content editing, Data Analysis.

Research Gateway

Adv For Editing Content

   No of Download : 116    Submit Your Rating     Cite This   Download        Certificate

SOCIOECONOMIC STATUS AND FINANCIAL BURDEN OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AMONG INDIANS: A REVIEW

    2 Author(s):  AMANJOT SINGH, DR. BALJEET SINGH

Vol -  8, Issue- 4 ,         Page(s) : 149 - 157  (2017 ) DOI : https://doi.org/10.32804/CASIRJ

Abstract

Chronic obstructive pulmonary disease (COPD) is considered by obstinate airflow obstruction and is at the alarming stage all around the world. COPD was the fifth most lethal disease among high-income countries and sixth among middle to low-income countries. It was recognized as a major health-related problem among developing nations.

  1. Aït-Khaled, N., Enarson, D., & Bousquet, J. (2001). Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. Bulletin of the World Health Organization, 79(10), 971-979.
  2. Altaf, M., Zubedi, A. M., Nazneen, F., Kareemulla, S., Ali, S. A., Aleemuddin, N. M., & Hazari, M. A. H. (2015). Cost-effectiveness analysis of three different combinations of inhalers for severe and very severe chronic obstructive pulmonary disease patients at a tertiary care teaching hospital of South India. Perspectives in clinical research, 6(3), 150.
  3. Arora, P., Kumar, L., Vohra, V., Sarin, R., Jaiswal, A., Puri, M. M., Rathi, D., & Chakraborty, P. (2014). Evaluating the technique of using inhalation device in COPD and bronchial asthma patients. Respiratory medicine, 108(7), 992-998.
  4. Bartal, M. (2005). COPD and tobacco smoke. Monaldi archives for chest disease, 63(4).
  5. Chaturvedi, R., Muzammil, K., Singh, N., Davey, S., & Singh, J. V. (2015). Prevalence of COPD in rural population, Muzaffarnagar. Indian Journal of Community Health, 27(4), 467-471.
  6. Gupta, D., Agarwal, R., Aggarwal, A. N., Maturu, V. N., Dhooria, S., Prasad, K. T.  K. T. Prasad,Inderpaul S. Sehgal, Lakshmikant B. Yenge, Aditya Jindal, Navneet Singh, A. G. Ghoshal , and S. K. Jindal, & Ghoshal, A. G. (2013). Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations. Lung India: official organ of Indian Chest Society, 30(3), 228.
  7. Hagstad, S., Bjerg, A., Ekerljung, L., Backman, H., Lindberg, A., Rönmark, E., and B. Lundbäck. 2014. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest, 145(6), 1298-1304.
  8. Halbert, R. J., Natoli, J. L., Gano, A., Badamgarav, E., Buist, A. S., and D. M. Mannino.2006. Global burden of COPD: systematic review and meta-analysis. European Respiratory Journal, 28(3), 523-532.
  9. Jindal, S. K., Aggarwal, A. N., Chaudhry, K., Chhabra, S. K., D Souza, G. A., Gupta, D., Katiyar, S.K., Kumar, R., Shah, B.  & Vijayan, V. K. (2006). A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian Journal of Chest Diseases and Allied Sciences, 48(1), 23.
  10. Jindal, S. K., Gupta, D., Aggarwal, A. N., & WHO-Government of India Biennium (2002-2003) Programme. (2004). Guidelines for management of chronic obstructive pulmonary disease (COPD) in India: a guide for physicians (2003). The Indian journal of chest diseases & allied sciences, 46(2), 137.
  11. Jindal, S. K., Gupta, D., Aggarwal, A. N., Jindal, R. C., & Singh, V. (2000). Study of the prevalence of asthma in adults in North India using a standardized field questionnaire. Journal of Asthma, 37(4), 345-351.
  12. KalagoudaMahishale, V., Angadi, N., Metgudmath, V., Lolly, M., Eti, A., & Khan, S. (2016). The Prevalence of Chronic Obstructive Pulmonary Disease and the Determinants of Underdiagnosis in Women Exposed to Biomass Fuel in India-a Cross Section Study. Chonnam medical journal, 52(2), 117-122.
  13. Lopez, A. D., & Murray, C. C. (1998). The global burden of disease, 1990–2020.
  14. Mahmood, T., Singh, R. K., Kant, S., Shukla, A. D., Chandra, A., & Srivastava, R. K. (2017). Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers. Lung India: official organ of Indian Chest Society, 34(2), 122.
  15. Mannino, D. M., & Buist, A. S. (2007). Global burden of COPD: risk factors, prevalence, and future trends. The Lancet, 370(9589), 765-773.
  16. Mannino, D. M., and A. S. Buist, 2007. Global burden of COPD: risk factors, prevalence, and future trends. The Lancet, 370(9589), 765-773.
  17. Maureen PM, Molken R, Feenstre TL. The Burden of Asthma and Chronic Obstructive Pulmonary Disease. Pharmacoeco. 2009; 19(2): 1–6. 
  18. Milewska, A., Rysiak, E., Zareba, I., Holownia, A., & Mroz, R. M. (2015). Costs of Treatment of Chronic Obstructive Pulmonary Disease. In Respirology (pp. 67-75). Springer International Publishing.
  19. Murthy KJR, Sastry JG. Economic burden of chronic obstructive pulmonary disease. National Commission on Macroeconomics and Health (NCMH) background papers. 2005. pp. 265–74. 
  20. Negi, H., Sarkar, M., Raval, A. D., Pandey, K., & Das, P. (2014). Health-related quality of life in patients with chronic obstructive pulmonary disease in North India. Journal of postgraduate medicine, 60(1), 7.
  21. Orneck T, et al. Clinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic pulmonary disease. Int J Med Sci. 2012; 9(4): 285–90.
  22. Patel, K. D., Lalwani, T., & Shah, K. (2014). Economic Burden in Direct Cost of Chronic Obstructive Pulmonary Disease at a Tertiary Care Teaching Hospital: A Prospective Observational Cohort Study. Indian Journal of Pharmacy Practice, 7(3), 61.
  23. Pauwels, R. A., &Rabe, K. F. 2004.Burden and clinical features of chronic obstructive pulmonary disease (COPD). The Lancet, 364(9434), 613-620.
  24. Pelicaric, D., Petanjek, B. B., Popovic, S. G., JaluÅ, T., and M. Bogdan. 2012. COPD among non-smokers. European Respiratory Journal, 40(Suppl 56), P3999.
  25. Pleasants R, Ohar J, Croft JB, et al. Chronic obstructive pulmonary disease and asthma – patient characteristics and health impairment. COPD. 2014;7:1–11. 
  26. Pleasants, R. A., Riley, I. L., & Mannino, D. M. (2016). Defining and targeting health disparities in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease, 11, 2475.
  27. Pleasants, R. A., Riley, I. L., & Mannino, D. M. (2016). Defining and targeting health disparities in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease, 11, 2475.
  28. Prescott, E., Lange, P., & Vestbo, J. (1999). Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. European Respiratory Journal, 13(5), 1109-1114.
  29. Ramanath KV, Sabith JK. Pharmacoeconomic Evaluation of Acute Exacerbations of COPD Treatment in a Rural Tertiary Care Hospital. Int J of Pharmace sci and res. 2012; 3(4): 1155–60 
  30. Reddy, K. S., Shah, B., Varghese, C., & Ramadoss, A. (2005). Responding to the threat of chronic diseases in India. The Lancet, 366(9498), 1744-1749.
  31. Sarkar, A., Javia, A., Pithadia, P., & Parmar, D. (2017). Why do Patients undergoing Chronic Obstructive Pulmonary Disease Treatment Turn Defaulters? A Follow up Study in a Tertiary Care Hospital in Jamnagar, India. Journal of clinical and diagnostic research: JCDR, 11(7), LC04.
  32. Schraufnagel DE, Blasi F, Kraft M, et al. An official American Thoracic Society/European Respiratory Society policy statement: disparities in respiratory health. Am J Respir Crit Care Med. 2013;188:865–871.
  33. Sinha, B., Vibha, R. S., & Chowdhury, R. (2017). An epidemiological profile of chronic obstructive pulmonary disease: A community-based study in Delhi. Journal of postgraduate medicine, 63(1), 29.
  34. Srivastava, K., Thakur, D., Sharma, S., & Punekar, Y. S. (2015). Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics, 33(5), 467-488.
  35. Taylor, J. D. (2010). COPD and the response of the lung to tobacco smoke exposure. Pulmonary pharmacology & therapeutics, 23(5), 376-383.
  36. Veettil, S. K., Salmia, M., Rajiah, K. I. N. G. S. T. O. N., & Kumar, S. B. (2012). Cost of acute exacerbation of COPD in patients attending government hospital in Kerala, India. Alcoholism, 30(30), 55-8.
  37. Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., & Stockley, R. A. 2013. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine, 187(4), 347-365.
  38. Walia, G. K., Vellakkal, R., and V. Gupta.,2016. Chronic obstructive pulmonary disease and its non-smoking risk factors in India. COPD: Journal of Chronic Obstructive Pulmonary Disease, 13(2), 251-261.
  39. World Health Organization. 2000. The Asia-Pacific perspective: redefining obesity and its treatment.
  40. http://www.who.int/mediacentre/factsheets/fs315/en/

*Contents are provided by Authors of articles. Please contact us if you having any query.






Bank Details